Jerzy Jankowski
Poznan University of Medical Sciences
6 Papers
39 Citations
Jerzy Jankowski is an academic researcher from Poznan University of Medical Sciences. The author has contributed to research in topics: Heart failure & Cardiotoxicity. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Coenzyme Q10 - A new player in the treatment of heart failure?
TL;DR: Current data from clinical trials indicate that CoQ10 can significantly reduce morbidity and mortality of heart failure patients in addition to guideline recommended pharmacotherapy.
29
The role of magnesium in cardiac arrhythmias.
TL;DR: Several studies have shown the beneficial effect of intravenous infusion of Mg during an attack of supraventricular tachycardia, indicating that the effectiveness of magnesium depends on the type of tachy Cardiac Arrhythmias.
16
Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
TL;DR: The article reviews the results of current studies on the use of cardiovascular drugs in the prevention of cardiotoxicity and finds the most promising cardioprotective drugs seem to be carvedilol, nebivolol, enalapril, and candesartan, as they prevent heart remodeling and correct elevated resting heart rate, which directly affects mortality.
10
Current approach for detection of sub-clinical left ventricular dysfunction associated with chemotherapy
TL;DR: The article describes the current knowledge concerning approaches for detection of sub-clinical left ventricular dysfunction associated with chemotherapy and identifies speckle tracking echocardiography and peak systolic global longitudinal strain appear to be the best measure.
3
Kardiotoksyczność leczenia przeciwnowotworowego
Dominika Neumann,Katarzyna Korzeniowska,Jerzy Jankowski,Anna Jabłecka +3 more
- 01 Jan 2016
TL;DR: Najlepiej poznane są powiklania kardiologiczne indukowane antracyklinami i trastuzumabem, lecz ich diagnostyka, prewencja i leczenie pozostają przedmiotem dalszych badan.